Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With

Edward L Hannan1, Ye Zhong1, Peter B Berger2

  • 1University at Albany, State University of New York, Rensselaer.

JAMA Cardiology
|December 29, 2017
PubMed

Insights

Incomplete revascularization (IR) after percutaneous coronary interventions (PCI) increases mortality risk, especially with severe stenosis, multiple vessels, or left anterior descending artery involvement. These findings highlight specific IR characteristics associated with worse patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Incomplete revascularization (IR) is common after percutaneous coronary interventions (PCI), but the impact of specific IR characteristics on patient outcomes is not well understood.
  • Existing research primarily compares complete versus incomplete revascularization, with limited focus on the nature of IR itself.

Purpose of the Study:

  • To investigate whether specific features of incomplete revascularization (IR) are associated with increased mortality risk in patients undergoing percutaneous coronary interventions (PCI).
  • To identify particular coronary vessel characteristics that may predict worse outcomes following PCI with IR.

Main Methods:

  • A multicenter study utilizing the New York PCI registry, including 41,639 patients with multivessel coronary artery disease undergoing PCI between 2010 and 2012.
  • Analysis focused on medium-term mortality, examining the association with the number of incompletely revascularized vessels, degree of stenosis, and involvement of the proximal left anterior descending artery, controlling for other mortality factors.
  • Study included patients with and without ST-elevation myocardial infarction (STEMI).

Main Results:

  • Incomplete revascularization (IR) was prevalent, occurring in 78% of STEMI patients and 71% of non-STEMI patients.
  • Patients with IR in a vessel with at least 90% stenosis, IR in two or more vessels, or IR involving the proximal left anterior descending artery demonstrated significantly higher mortality.
  • Specifically, IR in 2+ vessels (AHR 1.35 for STEMI, 1.17 for non-STEMI) and proximal LAD IR (AHR 1.31 for STEMI, 1.11 for non-STEMI) were linked to increased mortality.

Conclusions:

  • The nature of incomplete revascularization (IR) significantly impacts patient mortality after percutaneous coronary interventions (PCI).
  • Specific high-risk characteristics for IR include severe stenosis (≥90%), involvement of multiple vessels, and involvement of the proximal left anterior descending artery.
  • These findings underscore the importance of considering the specific features of IR when assessing patient risk and guiding treatment decisions post-PCI.
Abstract

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
360
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307